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where the costs were allocated to the different cost-centres. Capital costs were 
annualised cost of capital item with life expectancy of more than 1 year and recur-
rent cost were all inputs consumed within a year. Total costs were then allocated 
to the in-patient and out-patient services based on historical financial data with a 
ratio of 1: 4. This was then followed by a stepwise approach of allocating the ancillary 
department cost centres to the clinical department cost centres. The unit cost per 
patient visit was calculated based on the number of visits for each department. Base 
year of 2010 was used to calculate the cost and patients visits. Costs were calculated 
from the perspective of the hospital. Results: The cost per visit to the out-patient 
department averaged at MYR 96.83 (USD 29.34). The cost per visit to the medical 
department and surgical department was MYR 138.66 (USD 42.02) and 273.39 (USD 
82.84) respectively. ConClusions: The findings provide an estimate of the costs 
for out-patient visit. At the current minimal fee of MYR 5.00 (USD 1.5), the Ministry 
of Health is subsidising more than 95.0% of the health care cost for each patient. 
These estimates provide the policy-makers with an understanding of the cost data 
should they need to establish a cost basis for payment rates.
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objeCtives: With the roll-out of public hospital reform in China, several provinces 
have started to implement the zero markup pilots in both municipal- and county-
levels. As the pioneer, Zhejiang is the first pilot province that has zero markup policy 
fully implemented in all levels. The aim of this study is to investigate the outcomes 
of Zhejiang zero markup policy and thus to predict effect of the policy on health 
expenditure. Methods: Official documents of public hospital reform and relevant 
reports were revised for the detail of how the loss of hospitals resulted from the 
removal of markup was subsidized. Statistical comparison on expenses variety and 
physician behavior between Zhejiang and other cases in China was used. Results: 
Documents released by Zhejiang Government indicated the removal of drug markup 
should be subsidized through increasing service charge and governmental financial 
support. After 6 months of implementation, it was reported that drug expenditure in 
sample hospitals had decreased by 7.78%, with the percentage of drug expenditure 
out of total out-patient and in-patient expense reducing by 6.67% and 8.7% respec-
tively. Overall diagnostic income increased by 425.31%, whereas incomes generated 
by care fee, surgery fee and treatment fee increased by 138.77%, 45.75% and 43.65% 
respectively. Patients visiting were also observed increased with a decrease in aver-
age amount per prescription. ConClusions: Switch of a significant proportion of 
health care expenditure from drug expenses to service charge indicated changes 
in the structure of hospital’s income, through which the value of health care labor 
market was manifested and the non-profit nature of public hospitals was restored. 
However, hospitals may have incentives to increase the number of services they pro-
vide to patients, especially when local governmental subsidy is not in place timely. 
It is predicted that such circumstance may frequently occur during rolling out the 
policy as local governments across the country differ in their financial capacity. As 
a result, the user charge of patient will still account for a significant proportion of 
total health care expenditure.
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bACkgRound: Financial burden due to health care costs are high in India and a 
small percentage of the population are protected through any health insurance 
program. To protect people from high economic cost of illness, and reduces inequal-
ity in health care access government of Kerala introduced a comprehensive health 
insurance scheme. objeCtives: This study tries 1. To explore the factors affect-
ing the enrollment in Comprehensive Health Insurance Scheme, 2. To find out the 
health care utilization pattern among insured and associated factors. Methods: 
Exploratory Case study, both quantitative and qualitative Methods used to track 
the objectives of the study. An interview conducted on 150 insured households. 
In-depth interviews conducted on 10 kudumbasree (women support groups) groups 
and 10 key informants’ interviews were also done. Results: In addition to educa-
tion and health risk, awareness about the scheme is high especially among females. 
About 97.4% of respondents were from poor families and, 40.7 % don’t have any 
permanent income. APL family (above poverty line) registration is negligible (2.6%) 
only. Around 91.3% don’t have any other form of health insurance coverage. 42% 
respondents utilized the scheme and 34.0% of households have had history of 
chronic diseases. Majority of respondents (97.3%) registered through kudumbasree 
group. All respondents reported that coverage is not enough and out patients care 
should be included. Qualitative interviews revealed that many eligible members 
were excluded, and delay in settling of claims, provider choice is limited. Women 
empowerment in health related matters and enrollment is appreciable through 
Kudumbasree groups. ConClusions: Access to health care and access to medicine 
is increased. Concerted effort is needed for the successful implementation and 
sustainability of the scheme.
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objeCtives: In this paper, we use the panel data of China Health and Nutrition 
Survey (CHNS) in 2000, 2004 and 2006 to study the impact of the income per 
NHFPC had released the second edition of NEDL, which increased to 520 drugs and 
allowed all provinces to implement after appropriate addition. Until the end of 
February 2014, nine provinces in China had supplemented average 251 drugs (aver-
age 121 western medicines and 130 TCM) on the basis of 520 drugs. The most was 535 
in Xinjiang and the least is 57 in Gansu. (2) Meanwhile, China NDRC was planning 
to introduce low-priced drug list covering 890 drugs, the price control of which will 
be released if average daily cost is less than 3 RMB for western drugs or 5 RMB for 
TCM. (3) On February 27, 2014 Guangdong province had released “low-priced drugs 
list of non-essential drugs” including 1103 drugs, then plus essential drugs in the 
province, relatively cheap drugs that patients could afford are theoretically up to 
1902. ConClusions: (1) These two policies had provided quantitatively safeguard 
for patients access to relatively cheap drugs close to 2,000. (2) Chinese “parallel 
development” policy for TCM and Western Medicine will be insisted on for a long 
term. (3) It needs more scientific mechanism designed to avoid the lacks of“double 
envelop”tendering and distortion of doctors’ income.
HealTH care use & PolIcy sTuDIes – formulary Development
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objeCtives: Singapore ranks 6th in world’s health systems by WHO, yet spends 
proportionally less on health than any other high-income countries. We aimed to 
investigate how drugs are accessed and financed through the public health care 
system in Singapore Methods: Secondary research was conducted to identify and 
review relevant policy documents, published guidelines and reports on health care 
financing and drug access in the public health care setting. Relevant information 
was extracted and analysed independently by 2 reviewers with verification by a 
third reviewer. Results: The MOH maintains a Standard Drug List (SDL) which 
is divided into two parts, SDL 1 and SDL 2. Drugs included in SDL 1 follow closely 
WHO’s Essential Drug List while SDL 2 was introduced later to subsidise some 
expensive drugs. There are currently about 570 drug preparations listed in SDL. 
Subsidised patients pay S$1.40 per item for drugs in SDL 1 and 50% of the cost for 
drugs in SDL 2 by out-of-pocket or through their own or family members’ Medisave 
accounts. Non-subsidised patients pay the full cost of drugs in SDL. All patients pay 
the full cost for drugs not included in SDL. MediShield a state-run opt-out medi-
cal insurance scheme designed to cover medical expense including medications 
that Medisave alone would not be sufficient to cover. For those who cannot afford 
the subsidised charges, despite Medisave and MediShield coverage, Medifund is 
an endowment fund set up as a safety net to help needy Singaporeans. In 2010, 
Medication Assistance Fund (MAF) was launched to help eligible patients pay for 
selected expensive non-SDL drugs. MAF is means tested with up to 75% subsidy 
involving case-by-case evaluation for patients’ eligibility. ConClusions: The drug 
formulary and access schemes reflect the philosophy of shared responsibilities of 
public and individuals toward health in the public health care delivery in Singapore.
HealTH care use & PolIcy sTuDIes – Health care costs & management
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objeCtives: To evaluate the economic impact of Specialist Outpatient Clinic (SOC) 
Pharmacy interventions Methods: A retrospective study in Singapore General 
Hospital (SGH) SOC Pharmacy on the interventions made with physicians, between 
Aug 2012 and Oct 2012. Each intervention was analysed and assigned with an 
Estimated Cost of Avoidance (ECA) level, consented to by 3 pharmacists with varying 
clinical experience from 2 years to 15 years. The ECA level ranges from 1 to 8, with 1 
having the least economic impact and 7 having the greatest economic impact. An 
ECA level of 8 has no economic impact as it signify non-acceptance of interventions 
by physicians. Subsequently, the economic impact per month is calculated by the 
total number of interventions in each ECA level, multiplied by the respective cost 
of avoidance, pre-determined for each ECA level based on national / institution 
standards, in Singapore Dollars. Results: The economic impact of SOC Pharmacy 
interventions is estimated to be ~SGD 900,000 over 3 months, with an average of ~ 
SGD 300,000 per month. With an average of 23000 prescriptions per month, it is esti-
mated that our SOC Pharmacy interventions saves ~ SGD 13 per prescription. Unlike 
traditional, direct methods to estimate the economic impact of pharmacy interven-
tions, our results highlighted a great portion of cost savings to both institutions and 
patients, which are often neglected. ConClusions: Interventions performed by 
Pharmacy staff have a great impact on cost savings to institution and also patients.
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objeCtives: Health care services in Malaysia are widely available and accessible 
at a minimal cost. However, in pursuing with the health care reform, policy-makers 
and hospital managers need to know the unit cost for the purpose of planning and 
efficiency of providing the services. This study estimated the cost of out-patient 
services in a public hospital. Methods: The study was conducted in a 341 bedded 
hospital that provide secondary level care to 24,486 in-patients and 127,389 spe-
cialist out-patients in 2010. The costs were estimated using a step-down approach 
